Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

BridgeBio, Corcept rise; Aclaris Therapeutics, IAA fall

Por: ABC News Business March 07, 2023

thumbnail

NEW YORK -- Stocks that traded heavily or had substantial price changes Monday:Altria Group Inc., up 66 cents to $47.19.The maker of Marlboro cigarettes announced a $2.75 billion investment in electronic cigarette startup NJOY.Ciena Corp., up $1.80 $50.89.The developer of high-speed networking technology beat Wall Street’s first-quarter profit forecasts.BridgeBio Pharma Inc., up $5.65 to $16.52.The rare disease drug developer gave investors an... + full article



Similar News

Can ADC Therapeutics Strike Gold With Lymphoma Drug Zynlonta?

RTTNews USA Health January 18, 2023

thumbnailThis commercial-stage biotechnology company developing next-generation, targeted antibody drug conjugates is aiming to achieve double-digit year-over-year revenue growth for its lead drug.The company we are profiling today is ADC Therapeutics SA () and the drug in focus is... + más

Nkarta | RTTNews

Chicago White Sox pitcher Liam Hendriks says he will undergo cancer treatment after being diagnosed with non-Hodgkin's lymphoma | CBS News


Pills could replace daily injections in the near future

WPTV USA Nation November 30, 2022

thumbnailIf you or someone you love deals with a chronic disease, you're likely aware of injections. New research is indicating that in the not-too-distant future, that same medication and routine vaccinations might come in a pill form.For 10 years, biotech company has been working... + más

Op-Ed: Fentanyl pill producers used to mimic other pharmaceuticals, now they don't have to | Los Angeles Times

Hey FDA, Free the Birth Control Pill! | The Daily Beast


Aclaris Therapeutics, Pediatrix Therapeutics Ink License Deal For ATI-1777 In Greater China

RTTNews USA Health November 29, 2022

thumbnailBiopharmaceutical company Aclaris Therapeutics, Inc. () and Chinese therapeutic company Pediatrix Therapeutics, Inc. announced that the companies have entered into a license agreement.Under the license agreement, Aclaris has granted Pediatrix the exclusive rights to develop,... + más

Visconti: Pens And Inks For Fall | Forbes

Subscribe to HP Instant Ink and save $100s per year on ink | New York Post


Meta Platforms, Triumph Bancorp rise; IAA, Palantir fall

ABC News USA Business November 08, 2022

thumbnailNEW YORK -- Stocks that traded heavily or had substantial price changes Monday: Apple Inc., up 54 cents to $138.92Apple warned customers about delays on iPhone models because of precautions at a contractor in .Meta Platforms Inc., up $5.93 to $96.72.Facebook's parent... + más

Peter Thiel’s Palantir has struggled to win contracts since Trump left White House | New York Post

Palantir stock falls after slight earnings miss | CNBC


Ritchie Bros. Shares Tumble on US$7.4B Acquisition of IAA

MarketWatch USA Business November 07, 2022

thumbnailThe Canadian industrial auctioneer and seller of used heavy industrial equipment said IAA stockholders would receive for each of their shares US$10 in cash and 0.5804 of a share. The deal includes the assumption of US$1 billion of net debt. In total, the purchase price is... + más

Ritchie Bros. Shares Tumble on US$7.4B Acquisition of IAA | MarketWatch

Why ‘Bros’ is a hit movie to see in theaters for your zodiac sign | New York Post


Ritchie Bros. Shares Tumble on US$7.4B Acquisition of IAA

MarketWatch USA Business November 07, 2022

thumbnailThe Canadian industrial auctioneer and seller of used heavy industrial equipment said IAA stockholders would receive for each of their shares US$10 in cash and 0.5804 of a share. The deal includes the assumption of US$1 billion of net debt. In total, the purchase price is... + más

Ritchie Bros. Shares Tumble on US$7.4B Acquisition of IAA | MarketWatch

Why ‘Bros’ is a hit movie to see in theaters for your zodiac sign | New York Post


BridgeBio's NULIBRY Gets Marketing Authorization In The EU For An Ultra-rare Disease

RTTNews USA Health September 24, 2022

thumbnailBridgeBio Pharma Inc. () and Sentynl Therapeutics Inc., on Tuesday, announced that the European Commission has granted marketing authorization for NULIBRY for the treatment of patients with Molybdenum Cofactor Deficiency Type A.Molybdenum Cofactor Deficiency Type A (MoCD Type A)... + más

Apple Watch Ultra is worth $799 for serious athletes, but an unnecessary splurge for the rest of us | CNBC

iFixit teardown looks at the guts of the Apple Watch Ultra | The Verge



About iurex | Privacy Policy | Disclaimer |